FinTech
Race Oncology: Secures human ethics trial approval
Race Oncology Secures human ethics trial approvalRace Oncology (RAC) receives human ethics approval for the next stage of its clinical trial of Zantrene...
FinTech
Race Oncology: Appoints Damian Clarke-Bruce as CEO and MD
Race Oncology Appoints Damian Clarke-Bruce as CEO and MDRace Oncology (RAC) appoints Damian Clarke-Bruce as Managing Director and Chief Executive Officer, effective from...
FinTech
Race Oncology: Reports $1.8m in cash outflows
Race Oncology Reports $1.8m in cash outflowsRace Oncology (RAC) reports $1.8 million in cash outflows for the quarter, an increase from the $931,000...
FinTech
Race Oncology: Receives compelling preclinical breast cancer results
Race Oncology’s (RAC) preclinical research program has shown the Bisantrene treatment to be an effective chemotherapeutic agent
To test this, sixteen breast cancer...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
